HIV-1's high virulence might be an accident of evolution

June 16, 2006

The virulence characteristic of HIV-1—the virus predominantly responsible for human AIDS—might amount to an accident of evolution, new evidence reveals. A gene function lost during the course of viral evolution predisposed HIV-1 to spur the fatal immune system failures that are the hallmarks of AIDS, researchers report in the June 16, 2006 Cell.

AIDS has killed more than 25 million people since it was first recognized in 1981, according to The Joint United Nations Programme on HIV and AIDS. In 2005, an estimated 4.1 million were newly infected with the virus. While infection with related strains of "simian immunodeficiency virus" (SIV) is similarly rampant among many species of monkeys, naturally infected nonhuman primates usually don't suffer the symptoms associated with AIDS. The evidence now revealed by an international team of researchers is the first to offer an explanation for this striking difference.

The group found that a viral protein earlier shown to help the virus evade the immune system, thereby allowing the SIVs that infect monkeys to persist and multiply with high efficiency, also has a protective role in the host immune system. The viral Nef protein ratchets down the activation of critical agents of immunity called T cells following SIV infection, thereby limiting the detrimental effects otherwise caused by chronically strong immune activation.

The HIV-1 Nef protein, and those of its closest related simian viruses, however, lack this protective function, leaving those infected susceptible to the heightened immune activation associated with progression to full-blown AIDS, reports Frank Kirchhoff of the University of Ulm in Germany and his colleagues.

"Nef-mediated suppression of T cell activation is a fundamental property of primate lentiviruses that likely evolved to maintain viral persistence in the context of an intact host immune system," the researchers said. "The findings suggest that the gene function was lost during viral evolution in a lineage that gave rise to HIV-1 and may have predisposed the simian precursor of HIV-1 for greater pathogenicity in humans."

"Heightened immune activation is the only clear cut difference between pathogenic and non-pathogenic infections with the immunodeficiency viruses," Kirchhoff added. "The observed difference in Nef function may provide—for the first time—a mechanism to explain why many monkey species naturally infected with SIV do not develop disease."

Study coauthor Beatrice Hahn of the University of Alabama has previously shown that the two forms of HIV that infect humans originated from related SIVs found in different species of African primates. HIV-1—most closely related to an SIV strain found in chimpanzees—is the more virulent of the two human strains and the source of the majority of HIV infections throughout the world. The less pathogenic HIV-2 evolved from a virus that infects long-tailed relatives of baboons called sooty mangabeys. While HIV and SIV strains all infect T cells that are critical for a functional immune response, SIV usually does so without causing serious damage in their natural primate hosts.

Of more than 30 SIVs that have been molecularly characterized, all encode a Nef gene. However, Kirchhoff noted, functional information about the gene's role had been almost exclusively derived from the HIV-1 version of Nef. To get a broader evolutionary perspective in the current study, Kirchhoff's group examined nef gene variants taken from a variety of divergent SIV lineages.

Nef variants from the great majority of primate SIVs, including the less virulent human strain HIV-2, suppress the expression of a receptor normally found on the surface of T cells, making the immune cells less responsive to activation, the researchers found. In contrast, they report, the nef gene of HIV-1 and a subset of closely related SIVs failed to limit T cell activation and death.

"Intriguingly, this loss of Nef-mediated suppression of T cell activation appears to have occurred twice, once in the ancestor of a group of viruses infecting Cercopithecus monkeys, and once in SIVcpz, the ancestor of HIV-1 which infects chimpanzees," noted study coauthor Paul Sharp, of the University of Nottingham, who is a leading expert in HIV and SIV evolution.

"What these viruses have in common is a vpu gene, not found in other SIVs, and so it's tempting to speculate that the presence of vpu is somehow causally related to the change in Nef function," Sharp added.

The findings expand on previous studies that found that nef-deficient SIV failed to cause symptoms in a monkey species normally susceptible to disease, Kirchhoff said. Rhesus macaques infected with the mutant virus had extremely low viral loads and "either no pathogenicity, or a markedly protracted disease course." Similarly, humans infected with nef-defective HIV-1 progress to disease symptoms slowly, if at all.

Several Nef functions were found to be likely contributors to the effect, including the gene's ability to get around the immune system.

"The gene was shown to be important for viral pathogenicity," Kirchhoff said. "It appeared that Nef was a 'bad guy' because it enhanced persistence and replication of the virus."

The new findings suggest the gene's role may be less black and white. "SIV Nef not only facilitates SIV persistence but may act as a 'rheostat,' allowing high enough levels of T cell activation to ensure sufficient viral replication and transmission, while at the same time preventing escalation of immune activation to levels that may be harmful to the host," the researchers said.

The results also raise the possibility that treatments that could carefully limit the immune system in infected humans—mimicking the tight balance maintained in the other primates—might offer a new approach to HIV therapy, Kirchhoff said.

"A strong immune response can be good in the short term, but if sustained for a long time as in those with HIV, it can exhaust the immune system," he said. "If you could somehow dampen the response, it might effectively convert the condition to the more chronic, asymptomatic infection seen in monkeys."

Further studies by the team will examine whether SIVs carrying Nef genes artificially made incapable of limiting T cell activation might become more pathogenic in their natural monkey hosts. The group will also examine whether Nef variation among HIV-2 strains might explain differences in the rate of progression to disease in infected humans.

Cell Press

HIV-1 Integrase: Mechanism and Inhibitor Design (Wiley Series in Drug Discovery and Development)
by Nouri Neamati (Editor), Binghe Wang (Editor)

This book comprehensively covers the mechanisms of action and inhibitor design for HIV-1 integrase. It serves as a resource for scientists facing challenging drug design issues and researchers in antiviral drug discovery. Despite numerous review articles and isolated book chapters dealing with HIV-1 integrase, there has not been a single source for those working to devise anti-AIDS drugs against this promising target. But this book fills that gap and offers a valuable introduction to the field for the interdisciplinary scientists who will need to work together to design drugs that target HIV-1 integrase.

HIV-1: Molecular Biology and Pathogenesis: Viral Mechanisms, 2nd Edition (Advances in Pharmacology, Vol. 55)
by Kuan-Teh Jeang (Editor), J. Thomas August (Editor), Ferid Murad (Editor)

This volume covers the latest advances in the mechanisms of pathogenesis of the HIV-1 virus on target cells. Its companion volume, Advances in Pharmacology 56, shows how new developments in understanding the virus translate to the clinical setting.

I Know Someone with HIV/AIDS (Understanding Health Issues)
by Elizabeth Raum (Author)

This book introduces readers to what HIV/AIDS are, how they affect people, and what they can do to be a good friend to someone living with HIV/AIDS.

HIV: A Practical Approach Volume 1: Virology and Immunology
by Jonathan Karn (Editor)

AIDS is undeniably one of the most pressing medical emergencies of our era. It is now 12 years since the discovery of HIV and in spite of a world-wide research effort no proven method for controlling AIDS has been developed. HIV Volumes 1 and 2 are guides to studying HIV in the laboratory focusing on specialized techniques unique to this field. Both books provide the novice entering HIV research with clear instructions on how to perform standard experiments as well as including many novel methods described in detail for the first time.

Volume 1 describes studies of the virus and infected cells and covers techniques for handling HIV safely, for studying viral entry, replication and neutralization and basic immunological techniques.

Tuberculosis and AIDS: The Relationship Between Mycobacterium Tb and the HIV Type 1
by Lawrence L. Scharer (Author)

St. Luke's Roosevelt Hospital Center, New York City. Concise text for practitioners on the relationship between tuberculosis and AIDS. Covers epidemiology, pathogenesis, clinical presentation, diagnosis, treatment, and public health issues.

Mental Disorders in HIV-1 Infection and AIDS (Who Expert Series on Neuroscience)
by Mario Maj (Author), Fabrizio Starace (Author), N. Sartorius (Author)

HIV-1 infection has become a subject of increasing interest for psychiatrists. One source of interest is the fact that brain involvement represents a biological aspect of the infection and the disease; another the psychological impact of the notification of the infection and of the progression of the disease on affected individuals. This dichotomy is reflected by the first two sections of the book, which cover "organic" and "psychogenic" mental disorders. Attention is also paid to other mental disorders such as mood and acute psychotic disorders which can occur in HIV-seropositive subjects, and whose origins often remain unknown.

The Cellular Basis of Central Nervous System Hiv-1 Infection And the AIDS Dementia Complex
by Richard W Price (Author), John J Sidtis (Author)

In this exciting symposium, the editor brings to print important new information on AIDS and how HIV affects the brain. Each chapter focuses on one or more of the cell types that reside in or traffic through the central nervous system (CNS). Each of these cells is important to considerations of the pathogenesis of the CNS. Neurologists, AIDS physicians, and other professionals caring for AIDS patients will find that this “cell-based” view provides a unique perspective and that it will guide and stimulate future investigation of this clinically important and pathogenetically intriguing disorder. The editor also introduces some general considerations for therapeutic intervention of AIDS dementia complex (ADC).

The contributors to The Cellular Basis of Central Nervous System...

My life, a life story of a man infected: A Man's Life before and after HIV (Volume 1)
by Mr David H Donahue (Author), David H Donahue (Author)

This book is a detailed look at the life of a former Marine and electrician who grew up in an environment of abuse, alcoholism and suicide. It follows the author from a childhood of abuse to his fathers suicide and a life of struggle. From a successful stint in the U.S. Marine Corps to homelessness and success as an electrician and a final fall when diagnosed with full blown AIDS. This is a story of a man who through all of complications continued to have hope. Inspirational and heartbreaking.

Cannabis Therapeutics in HIV/Aids (Journal of Cannabis Therapeutics, V. 1, No. 3/4)
by Ethan B Russo (Author)

Explore the controversial subject of cannabis therapeutics for HIV/AIDS patients!

Cannabis Therapeutics in HIV/AIDS provides a scientific view of the benefits of marijuana in helping to increase appetite, ease the symptoms of HIV/AIDS, and improve quality of life for patients. Dr. Ethan Russo, editor of the Journal of Cannabis Therapeutics, has assembled a collection of first-rate information from clinicians, researchers, and patients. Based on scientific research, this book offers insights into how using cannabis has helped patients deal with the symptoms of HIV/AIDS.

This informative book contains: a broad medical overview of the pertinent topics of interest with respect toAIDS and its treatment an insider’s view on the twenty-year history of the discovery of AIDS...

Psychological Medicine of HIV Infection (Oxford Medical Publications)
by Josï¿1/2 Catalï¿1/2n (Author), Adrian Burgess (Author), Ivana Klimes (Author), Brian Gazzard (Contributor)

The field of mental health aspects of HIV infection has grown substantially in recent years. This is the first book that provides an up-to-date, comprehensive, and practical review of the mental health consequences of HIV infection both for those infected and affected by the condition. The psychological, psychiatric, and brain related consequences of the infection are discussed in depth, and detailed guidelines for the assessment and management of mental health problems are given. Burn-out in professional carers and volunteers is reviewed. Prevention of the spread of HIV infection depends essentially on behavior change and here, preventive strategies that work are examined in detail. The role of psychological factors in long-term survivors of HIV infection is discussed critically.